8-K: Plexus Corp. Announces Strong Fiscal Third Quarter Results and Upbeat Q4 Guidance

Plexus Corp. reported solid fiscal third quarter results, exceeding expectations for non-GAAP operating margin and EPS, and provided positive guidance for the fiscal fourth quarter.

Summary

• Plexus Corp. announced its financial results for the fiscal third quarter ended June 29, 2024.
• The company reported revenue of $961 million, which was within their guidance range.
• GAAP operating margin was 4.1%, and GAAP diluted EPS was $0.91.
• Non-GAAP operating margin was 5.8%, and non-GAAP diluted EPS was $1.45, exceeding guidance.
• These non-GAAP results exclude $0.24 of stock-based compensation expense and $0.30 of restructuring and other charges, net of tax.
• Plexus initiated fiscal fourth quarter 2024 revenue guidance of $990 million to $1.03 billion.
• They expect GAAP diluted EPS of $1.14 to $1.29, including $0.36 of stock-based compensation expense.
• Fiscal fourth quarter 2024 non-GAAP EPS guidance is $1.50 to $1.65, excluding stock-based compensation expense.
• The company won 35 manufacturing programs during the quarter, representing $279 million in annualized revenue when fully ramped into production.
• They generated fiscal third quarter free cash flow of $114 million, contributing to fiscal year-to-date free cash flow of $147 million.
• Plexus repurchased $18.6 million of their shares at an average price of $100.64 per share.
• They have $19.5 million remaining under their existing $50.0 million repurchase authorization.
• The company anticipates delivering in excess of $150 million of free cash flow in fiscal 2024.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to strong financial results, exceeding expectations, and positive future guidance. The company's focus on growth and efficiency is also encouraging.

Positives

• Plexus exceeded expectations for non-GAAP operating margin and EPS in the third quarter.
• The company generated the second-best quarterly free cash flow in its history.
• They achieved a record contribution within the Healthcare/Life Sciences sector for new manufacturing program wins.
• Plexus is seeing increasing market sector diversification in demand for their engineering solutions.
• The company's cash cycle improved to 83 days, which is three days better than expected and eight days lower sequentially.
• Plexus reduced its borrowing by $89 million during the quarter.
• Management expects continued strong free cash flow generation in fiscal 2025.
• The company is witnessing signs of strengthening demand across all market sectors.
• Plexus expects sequential expansion in revenue, robust operating margin performance, and sequential growth in EPS in the fourth quarter.
• They anticipate meaningful EPS growth in fiscal 2025.

Negatives

• GAAP operating margin was 4.1%, which is lower than the non-GAAP margin.
• GAAP diluted EPS was $0.91, which is lower than the non-GAAP EPS.
• The company incurred restructuring and other charges, net of tax, of $0.30 in the third quarter.
• Stock-based compensation expense impacted both GAAP and non-GAAP results.

Risks

• The company faces risks related to the ability to realize anticipated savings from restructuring.
• They are exposed to the effects of inflationary pressures on costs of production and profitability.
• Shortages and delays in obtaining components could impact their operations.
• Customer delays, changes, cancellations, or forecast inaccuracies could affect their revenue.
• The company is subject to the economic performance of the industries, sectors, and customers they serve.
• They face risks related to litigation and regulatory investigations.
• Tariffs, trade disputes, and other trade protection measures could impact their business.
• The company is exposed to the risks of concentration of work for certain customers.
• New programs and facilities carry risks such as start-up costs and potential inability to execute.
• Fluctuations in currency values could affect their financial results.

Future Outlook

Plexus anticipates a strong finish to fiscal 2024 with sequential expansion in revenue, robust operating margin performance, sequential growth in EPS, and continued free cash flow generation. They expect sustained revenue growth momentum into fiscal 2025, capitalizing on market sector strength and new program ramps.

Management Comments

• Todd Kelsey, President and CEO, stated that the team delivered superior operational performance for the fiscal third quarter, enabling outstanding financial results.
• Mr. Kelsey noted that revenue was within guidance, while non-GAAP operating margin and EPS exceeded guidance.
• Mr. Kelsey highlighted the record contribution within Healthcare/Life Sciences for new manufacturing program wins.
• Patrick Jermain, Executive Vice President and CFO, commented that the $114 million of free cash flow significantly exceeded expectations.
• Mr. Jermain noted that progress on working capital initiatives contributed to the strong performance.
• Mr. Jermain stated that they anticipate delivering in excess of $150 million of free cash flow in fiscal 2024.
• Mr. Kelsey added that they are witnessing signs of strengthening demand across each of their market sectors.

Industry Context

The announcement reflects a positive trend for Plexus, indicating strong operational performance and growth in key market sectors. This is particularly relevant in the context of the broader electronics manufacturing services industry, where companies are navigating supply chain challenges and fluctuating demand. Plexus's focus on diversification and new program wins positions them well for future growth.

Comparison to Industry Standards

• Plexus's non-GAAP operating margin of 5.8% is competitive with other electronics manufacturing services (EMS) providers, such as Jabil and Flex, which typically report adjusted operating margins in the 4-6% range.
• The company's free cash flow generation of $114 million in the quarter is a strong performance, indicating efficient capital management, which is a key metric for investors in the EMS sector.
• The new program wins of $279 million in annualized revenue demonstrate Plexus's ability to secure new business, which is crucial for long-term growth and is a key performance indicator compared to competitors.
• Plexus's focus on Healthcare/Life Sciences, Aerospace/Defense, and Industrial sectors aligns with industry trends where these sectors are experiencing growth and demand for complex manufacturing solutions.
• The company's cash cycle of 83 days is a positive indicator of efficient working capital management, which is a key area of focus for EMS companies to maintain profitability and liquidity.

Stakeholder Impact

• Shareholders will benefit from the strong financial performance, share repurchases, and positive future outlook.
• Employees may experience job security due to the company's growth and success.
• Customers will benefit from Plexus's ability to deliver high-quality manufacturing services.
• Suppliers may see increased business opportunities due to Plexus's growth.
• Creditors will benefit from the company's strong cash flow and debt reduction efforts.

Next Steps

• Plexus will continue to execute upon the remaining $19.5 million of their current share repurchase authorization during the fourth quarter of fiscal 2024.
• The company will focus on capitalizing upon Aerospace/Defense market sector strength, increasing Healthcare/Life Sciences customer forecasts, and improved semiconductor capital equipment and broadband communications demand.
• Plexus will continue to optimize their business for greater efficiency during fiscal 2024.
• They will continue free cash flow deployment toward debt reduction and share repurchases.
• Plexus will host a conference call and webcast on July 25, 2024, to discuss the results.

Key Dates

Keywords

Plexus, Manufacturing, Electronics, Financial Results, Earnings, Revenue, Operating Margin, EPS, Free Cash Flow, Share Repurchase, Guidance, Healthcare, Aerospace, Industrial